{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T15:16:56Z","timestamp":1687965416764},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.gofs.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T00:52:36Z","timestamp":1520729556000},"page":"231-247","source":"Crossref","is-referenced-by-count":3,"title":["Traitement m\u00e9dical de l\u2019endom\u00e9triose\u00a0: prise en charge de la douleur et de l\u2019\u00e9volution des l\u00e9sions par traitement hormonal. RPC Endom\u00e9triose CNGOF-HAS"],"prefix":"10.1016","volume":"46","author":[{"given":"S.","family":"Geoffron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sauvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Wattier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.02.011_bib0005","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2018.02.011_bib0010","doi-asserted-by":"crossref","DOI":"10.23736\/S0026-4784.17.04031-X","article-title":"Abdominal wall endometriosis following cesarean section: a study of the growth rate of parietal endometriosis implants","author":"Touleimat","year":"2017","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0015","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/resp.12610","article-title":"Clinical characteristics of catamenial and non-catamenial thoracic endometriosis-related pneumothorax","volume":"20","author":"Fukuoka","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.gofs.2018.02.011_bib0020","first-page":"QR04","article-title":"Thoracic endometriosis syndrome: a veritable pandora's box","volume":"10","author":"Nair","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.gofs.2018.02.011_bib0025","first-page":"18","article-title":"Multidisciplinary treatment for thoracic and abdominopelvic endometriosis","author":"Nezhat","year":"2014","journal-title":"JSLS"},{"key":"10.1016\/j.gofs.2018.02.011_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13019-016-0462-7","article-title":"Hormonal therapy after the operation for catamenial pneumothorax \u2013\u00a0is it always necessary?","volume":"11","author":"Subotic","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.gofs.2018.02.011_bib0035","series-title":"Recommandations pour la pratique clinique\u00a0: prise en charge de l\u2019endom\u00e9triose","author":"CNGOF","year":"2006"},{"key":"10.1016\/j.gofs.2018.02.011_bib0040","doi-asserted-by":"crossref","unstructured":"Leyland N, Casper R, Laberge P, Singh SS. Endometriosis: diagnosis and management. J Obstet Gynaecol Can 32: S1-S32, 2010","DOI":"10.1016\/S1701-2163(16)34589-3"},{"key":"10.1016\/j.gofs.2018.02.011_bib0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0050","series-title":"Endometriosis: diagnosis and management","author":"NICE","year":"2017"},{"key":"10.1016\/j.gofs.2018.02.011_bib0055","series-title":"Niveau de preuve et gradation des recommandations de bonne pratique \u2013\u00a0\u00c9tat des lieux","author":"HAS","year":"2013"},{"key":"10.1016\/j.gofs.2018.02.011_bib0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/aogs.12326","article-title":"Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study","volume":"93","author":"Leone Roberti Maggiore","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2018.02.011_bib0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)55792-6","article-title":"Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","article-title":"A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"60","author":"Vercellini","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijgo.2010.11.015","article-title":"Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device","volume":"113","author":"Ferrero","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.gofs.2018.02.011_bib0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2014.10.036","article-title":"Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment","volume":"183","author":"Morotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0085","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0015-0282(16)57530-X","article-title":"Prospective randomized double-blind trial of 3\u00a0versus 6\u00a0months of nafarelin therapy for endometriosis associated pelvic pain","volume":"63","author":"Hornstein","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0095","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejogrb.2015.06.006","article-title":"Effects of low dose oral contraceptive pill containing drospirenone\/ethinylestradiol in patients with endometrioma","volume":"191","author":"Taniguchi","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/09513590.2011.634936","article-title":"A new oral contraceptive regimen for endometriosis management: preliminary experience with 24\/4-day drospirenone\/ethinylestradiol 3mg\/20mcg","volume":"28","author":"Mabrouk","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0110","first-page":"CD001019","article-title":"Oral contraceptives for pain associated with endometriosis","author":"Davis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.02.011_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2014.05.016","article-title":"Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura","volume":"179","author":"Morotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0120","first-page":"CD002122","article-title":"Progestagens and anti-progestagens for pain associated with endometriosis","author":"Brown","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.02.011_bib0125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0015-0282(16)56991-X","article-title":"A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis","volume":"62","author":"Overton","year":"1994","journal-title":"Fertil Steril"},{"issue":"Suppl. 1","key":"10.1016\/j.gofs.2018.02.011_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09513590701669583","article-title":"Effective post-laparoscopic treatment of endometriosis with dydrogesterone","volume":"23","author":"Trivedi","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09513598709082692","article-title":"Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis","volume":"1","author":"Telimaa","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(96)70152-7","article-title":"Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis","volume":"175","author":"Vercellini","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2008.07.017","article-title":"Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis \u2013\u00a0a pilot study","volume":"79","author":"Walch","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.02.011_bib0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(00)01759-3","article-title":"Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis","volume":"75","author":"Fedele","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0155","first-page":"CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Brown","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.02.011_bib0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2009.08.003","article-title":"Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue","volume":"81","author":"Ferreira","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.02.011_bib0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0010-7824(95)00127-V","article-title":"Enlarged follicles in women using oral contraceptives","volume":"52","author":"Broome","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.02.011_bib0170","first-page":"637","article-title":"Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant","volume":"48","author":"Bahamondes","year":"2003","journal-title":"J Reprod Med"},{"key":"10.1016\/j.gofs.2018.02.011_bib0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.2002.00805.x","article-title":"Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy","volume":"20","author":"Inki","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0180","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.contraception.2005.12.012","article-title":"Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants","volume":"73","author":"Hidalgo","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.02.011_bib0185","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(98)00019-3","article-title":"Effects of triptorelin versus placebo on the symptoms of endometriosis","volume":"69","author":"Bergqvist","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0190","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1067\/mob.2000.106846","article-title":"Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial","volume":"182","author":"Miller","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0195","first-page":"413","article-title":"Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group","volume":"42","author":"Agarwal","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.gofs.2018.02.011_bib0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9378(88)90128-7","article-title":"Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis","volume":"158","author":"Lemay","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0205","first-page":"253","article-title":"A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310\u00a0Study Group","volume":"323","author":"Dawood","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.gofs.2018.02.011_bib0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0015-0282(16)60543-5","article-title":"Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study","volume":"51","author":"Dmowski","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0215","first-page":"CD001297","article-title":"Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density","author":"Sagsveen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.02.011_bib0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00404-014-3230-8","article-title":"Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis","volume":"290","author":"Wu","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.02.011_bib0225","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/humrep\/deh250","article-title":"One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial","volume":"19","author":"Fernandez","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0230","article-title":"The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: a Randomized Controlled Trial","author":"Sadler Gallagher","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/AOG.0000000000000964","article-title":"Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a Randomized Controlled Trial","volume":"126","author":"DiVasta","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0240","doi-asserted-by":"crossref","first-page":"934164","DOI":"10.1155\/2015\/934164","article-title":"treatment of endometriosis with the GnRHa deslorelin and add-back estradiol and supplementary testosterone","volume":"2015","author":"Agarwal","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.gofs.2018.02.011_bib0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00404-012-2581-2","article-title":"Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies","volume":"287","author":"Ferrero","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.02.011_bib0250","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0255","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1067\/mob.2000.106817","article-title":"Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial","volume":"183","author":"Muzii","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fertnstert.2008.09.052","article-title":"Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial","volume":"93","author":"Seracchioli","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0265","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.fertnstert.2009.03.083","article-title":"Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial","volume":"94","author":"Seracchioli","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0270","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.fertnstert.2013.07.008","article-title":"Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study","volume":"100","author":"Vlahos","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0275","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/09513590.2013.819085","article-title":"Oral contraceptive pills for endometriosis after conservative surgery: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0280","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejogrb.2009.07.003","article-title":"Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo","volume":"147","author":"Sesti","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0285","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/humrep\/dep259","article-title":"Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis","volume":"24","author":"Seracchioli","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0290","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2007.01.053","article-title":"Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial","volume":"88","author":"Sesti","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0295","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.fertnstert.2009.01.071","article-title":"Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis","volume":"93","author":"Vercellini","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajog.2015.08.074","article-title":"Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis","volume":"214","author":"Muzii","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000337713","article-title":"Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial","volume":"74","author":"Cheewadhanaraks","year":"2012","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.gofs.2018.02.011_bib0310","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jog.12030","article-title":"Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients","volume":"39","author":"Morelli","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.gofs.2018.02.011_bib0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2006.08.002","article-title":"Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis","volume":"135","author":"Razzi","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0320","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/humrep\/det041","article-title":"Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life","volume":"28","author":"Vercellini","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0325","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/humrep\/des313","article-title":"Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I.\u00a0Effect on pain during intercourse and patient satisfaction","volume":"27","author":"Vercellini","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0330","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.fertnstert.2006.12.077","article-title":"Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis","volume":"88","author":"Razzi","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0335","first-page":"CD005072","article-title":"Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery","author":"Abou-Setta","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.02.011_bib0340","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0300060513479865","article-title":"Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis","volume":"41","author":"Lan","year":"2013","journal-title":"J Int Med Res"},{"key":"10.1016\/j.gofs.2018.02.011_bib0345","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fertnstert.2010.08.042","article-title":"Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue","volume":"95","author":"Bayoglu Tekin","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0350","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/AOG.0b013e31824264c3","article-title":"Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial","volume":"119","author":"Tanmahasamut","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0355","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2006.10.034","article-title":"A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis","volume":"136","author":"Loverro","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0360","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jcph.485","article-title":"Initiation of GnRH agonist treatment on 3\u20135\u00a0days postoperatively in endometriosis patients: a randomized controlled trial","volume":"55","author":"Gong","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0365","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.fertnstert.2006.11.044","article-title":"The levonorgestrel-releasing intrauterine system and endometriosis staging","volume":"87","author":"Gomes","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0370","first-page":"3050","volume":"25","author":"Lee","year":"2010","journal-title":"Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0375","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/aogs.12294","article-title":"Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence","volume":"93","author":"Cho","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2018.02.011_bib0380","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.fertnstert.2007.11.027","article-title":"Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery","volume":"91","author":"Jee","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0385","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0412.2012.01470.x","article-title":"Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis","volume":"92","author":"Vercellini","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2018.02.011_bib0390","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ajog.2007.11.010","article-title":"Postoperative oral contraceptive exposure and risk of endometrioma recurrence","volume":"198","author":"Vercellini","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0395","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/humrep\/dep297","article-title":"Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision","volume":"24","author":"Takamura","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2018.02.011_bib0400","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fertnstert.2008.09.052","article-title":"Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial","volume":"93","author":"Seracchioli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2018.02.011_bib0405","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00404-013-2841-9","article-title":"Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?","volume":"288","author":"Cucinella","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.02.011_bib0410","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jmig.2010.11.004","article-title":"Oral estroprogestins after laparoscopic surgery to excise endometriomas: continuous or cyclic administration? Results of a multicenter randomized study","volume":"18","author":"Muzii","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.gofs.2018.02.011_bib0415","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00404-015-3641-1","article-title":"Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review","volume":"292","author":"Zorbas","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.02.011_bib0420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1479-828X.2010.01152.x","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial","volume":"50","author":"Wong","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918300436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918300436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T20:42:44Z","timestamp":1660596164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918300436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2468718918300436"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.02.011","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}